Cited 0 times in Scipus Cited Count

Financial Benefits of Renal Dose-Adjusted Dipeptidyl Peptidase-4 Inhibitors for Patients with Type 2 Diabetes and Chronic Kidney Disease

DC Field Value Language
dc.contributor.authorChoe, HJ-
dc.contributor.authorKo, YH-
dc.contributor.authorMoon, SJ-
dc.contributor.authorAhn, CH-
dc.contributor.authorHa, KH-
dc.contributor.authorLee, H-
dc.contributor.authorBae, JH-
dc.contributor.authorJoo, HJ-
dc.contributor.authorLee, H-
dc.contributor.authorSon, JW-
dc.contributor.authorKim, DJ-
dc.contributor.authorKim, SG-
dc.contributor.authorKim, K-
dc.contributor.authorCho, YM-
dc.date.accessioned2024-10-11T07:49:41Z-
dc.date.available2024-10-11T07:49:41Z-
dc.date.issued2024-
dc.identifier.issn2093-596X-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/32896-
dc.description.abstractBackground: Dipeptidyl peptidase-4 (DPP4) inhibitors are frequently prescribed for patients with type 2 diabetes; however, their cost can pose a significant barrier for those with impaired kidney function. This study aimed to estimate the economic benefits of substituting non-renal dose-adjusted (NRDA) DPP4 inhibitors with renal dose-adjusted (RDA) DPP4 inhibitors in patients with both impaired kidney function and type 2 diabetes. Methods: This retrospective cohort study was conducted from January 1, 2012 to December 31, 2018, using data obtained from common data models of five medical centers in Korea. Model 1 applied the prescription pattern of participants with preserved kidney function to those with impaired kidney function. In contrast, model 2 replaced all NRDA DPP4 inhibitors with RDA DPP4 inhibitors, adjusting the doses of RDA DPP4 inhibitors based on individual kidney function. The primary outcome was the cost difference between the two models. Results: In total, 67,964,996 prescription records were analyzed. NRDA DPP4 inhibitors were more frequently prescribed to patients with impaired kidney function than in those with preserved kidney function (25.7%, 51.3%, 64.3%, and 71.6% in patients with estimated glomerular filtration rates [eGFRs] of ≥60, <60, <45, and <30 mL/min/1.73 m2, respectively). When model 1 was applied, the cost savings per year were 7.6% for eGFR <60 mL/min/1.73 m2 and 30.4% for eGFR <30 mL/min/1.73 m2. According to model 2, 15.4% to 51.2% per year could be saved depending on kidney impairment severity. Conclusion: Adjusting the doses of RDA DPP4 inhibitors based on individual kidney function could alleviate the economic burden associated with medical expenses.-
dc.language.isoen-
dc.subject.MESHAged-
dc.subject.MESHCost-Benefit Analysis-
dc.subject.MESHDiabetes Mellitus, Type 2-
dc.subject.MESHDipeptidyl-Peptidase IV Inhibitors-
dc.subject.MESHFemale-
dc.subject.MESHGlomerular Filtration Rate-
dc.subject.MESHHumans-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHRenal Insufficiency, Chronic-
dc.subject.MESHRepublic of Korea-
dc.subject.MESHRetrospective Studies-
dc.titleFinancial Benefits of Renal Dose-Adjusted Dipeptidyl Peptidase-4 Inhibitors for Patients with Type 2 Diabetes and Chronic Kidney Disease-
dc.typeArticle-
dc.identifier.pmid39086276-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11375300-
dc.subject.keywordCommon data model-
dc.subject.keywordCost savings-
dc.subject.keywordDiabetes mellitus, type 2-
dc.subject.keywordDipeptidyl-peptidase IV inhibitors-
dc.subject.keywordRenal insufficiency, chronic-
dc.contributor.affiliatedAuthorHa, KH-
dc.contributor.affiliatedAuthorKim, DJ-
dc.type.localJournal Papers-
dc.identifier.doi10.3803/EnM.2024.1965-
dc.citation.titleEndocrinology and metabolism (Seoul, Korea)-
dc.citation.volume39-
dc.citation.number4-
dc.citation.date2024-
dc.citation.startPage622-
dc.citation.endPage631-
dc.identifier.bibliographicCitationEndocrinology and metabolism (Seoul, Korea), 39(4). : 622-631, 2024-
dc.identifier.eissn2093-5978-
dc.relation.journalidJ02093596X-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Endocrinology & Metabolism
Files in This Item:
39086276.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse